<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:department>MRC Ctr for Developmental Neurobiology</gtr:department><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/D8930BAE-1B71-44F6-B274-68147131CA67"><gtr:id>D8930BAE-1B71-44F6-B274-68147131CA67</gtr:id><gtr:firstName>Juan</gtr:firstName><gtr:surname>Burrone</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0600197"><gtr:id>30F38894-AB24-4807-A1BD-E3E57CB649C7</gtr:id><gtr:title>The formation of a synapse: measuring vesicle cycling in growth cones and developing presynaptic terminals</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0600197</gtr:grantReference><gtr:abstractText>Neurons in the brain communicate with each other at specialized sites called synapses. During brain development a large number of neurons (about 10 billion) make an astonishingly large number of synaptic connections (about 100 trillion) to form a functional brain. Not surprisingly, an important question in neuroscience is to understand how synapses are formed and how these connections pass information from one neuron to the next. At the synapse, the transfer of information is carried out by the release of packets of neurotransmitter released from a presynaptic neuron onto specific receptors on a postsynaptic neuron. Neurotransmitter is stored inside membrane vesicles and is released by the fusion of vesicles with the plasma membrane, which expels the neurotransmitter towards the postsynaptic neuron. The membrane from the vesicle is subsequently retrieved from the plasma membrane to be refilled with neurotransmitter and recycled for use once again. An important aspect of this vesicle cycle is that it is tightly controlled by the activity of a neuron. The research proposed here will focus on understanding how a presynaptic terminal forms and matures to provide such an exquisitely controlled system for releasing neurotransmitter. For this purpose I will use especially designed fluorescent probes that report vesicle cycling in real time by showing flashes of fluorescence every time a vesicle fuses with the plasma membrane. 
Before a neuron forms a synapse it must first reach its target neuron. This process of axon pathfinding relies on a special compartment at the tip of the axon, the growth cone, which acts as a navigator, guiding the axon to its correct target. The formation of a presynaptic terminal can be seen as a progression of events spanning the initial growth cone motility involved in axon pathfinding, followed by the stabilization of the growth cone at the target neuron and the formation of a synapse. Throughout all these processes, vesicle cycling also develops and matures: from an initial mixed form of vesicle cycling at the growth cone to a purely activity-dependent form at mature terminals. Here, I will study how vesicle cycling matures and results in a functional presynaptic terminal that releases neurotransmitter. Understanding these events will help uncover how connections in the brain form during development and help us understand neurological diseases where this process has gone wrong.</gtr:abstractText><gtr:technicalSummary>During development neurons grow axons and dendrites to form synaptic connections in the brain. A key question in the field of brain development is to understand how synapses form to establish a functional network of interconnected neurons. The overall aim of this proposal is to understand how a presynaptic terminal is formed and becomes competent to release neurotransmitter through a tightly controlled activity-dependent vesicle cycle. Our approach will be to assay how vesicle cycling matures throughout the different stages in the formation of a presynaptic terminal: from the original moments of growth cone motility and axon pathfinding, to the stabilization of the growth cone and formation of a presynaptic terminal. For this purpose I will use genetically encoded reporters of neuronal activity which will allow me to label distinct vesicle pools and assess their rates of cycling. The better known of these is synaptopHluorin (spH), which is a fusion protein between the synaptic vesicle protein VAMP2 (also known as synaptobrevin 2) and a pH sensitive EGFP (also known as pHluorin). At rest, this reporter is quenched by the acidic pH of the lumen of the vesicle, but increases its fluorescence upon vesicle fusion and exposure of the lumen to the more basic extracellular pH. In this way rates of exocytosis and endocytosis can be directly measured.
The growth cone has at least two very different vesicle cycling modes, which draw from two distinct pools of vesicles. Importantly, these pools use two different isoforms of the synaptic vesicle protein VAMP: VAMP7 is found on vesicle that undergo a constitutive form of vesicle cycling needed for growth cone motility, whereas VAMP2 is present on vesicles which undergo an activity-dependent form of vesicle cycling, much like in mature presynaptic terminals. I will exploit this molecular distinction by using the VAMP2-based optical reporter of vesicle cycling spH to label the activity dependent pool of vesicles and, similarly, a VAMP7-based reporter recently described as TiV-spH, to label the constitutive pool. By expressing these reporters in individual neurons I will assess how vesicle cycling occurs at a growth cone. More importantly, I will also study how molecular guidance cues and electrical activity, which are crucial for axon pathfinding, affect vesicle cycling at a growth cone. Finally, as the system develops, I will establish how vesicle cycling matures to become a presynaptic terminal releasing neurotransmitter in an activity-dependent manner.</gtr:technicalSummary><gtr:fund><gtr:end>2010-09-30</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>560644</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Centre for Developmental Neurobiology</gtr:department><gtr:description>Developing new genetically-encoded tools to study synapse function</gtr:description><gtr:id>7A5ED0C9-3697-4666-B800-21316C67CE83</gtr:id><gtr:impact>resulted in one publication (J. Neurosci., 2010) and currently writing joint grant proposal.</gtr:impact><gtr:partnerContribution>Made new probe and tested it in zebrafish retino-tectal system.</gtr:partnerContribution><gtr:piContribution>We characterize a new genetically-encoded probe in hippocampal neurons. Findings will be published in near future.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>315000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Project grant</gtr:description><gtr:end>2010-03-02</gtr:end><gtr:fundingOrg>The Wellcome Trust Ltd</gtr:fundingOrg><gtr:id>6454EA77-455B-4470-88CA-4BF2BA88EF7C</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>250000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC Equipment Grant</gtr:description><gtr:end>2008-11-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>98E7DF2B-5A19-4A87-ADC3-23443DD36ECA</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2007-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>590000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Project Grant</gtr:description><gtr:end>2013-06-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>4DC90CD9-C659-4332-8487-463A51FB095F</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Lister Institute for Preventative Medicine Prize</gtr:description><gtr:end>2014-07-02</gtr:end><gtr:fundingOrg>Lister Institute of Preventive Medicine</gtr:fundingOrg><gtr:id>4FE3AB98-3D5D-4935-9414-84C8F8965D8C</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-08-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We have developed a technique for labelling presynaptic vesicle proteins by combining in vivo biotinylation of transmembrane proteins together with irreversible tagging with fluorescent streptavidin. Our approach is an adaptation of a previously reported tool used to label surface antibodies and other transmembrane proteins, including postsynaptic receptors. We generated a fusion protein between the presynaptic vesicle protein, VAMP2, and a biotin acceptor peptide (BAP) that is specifically recognised by the biotin ligase enzyme BirA. The BAP domain was fused to the luminal end (C-terminus) of VAMP2 that is topologically equivalent to the extracellular domain. We used an engineered version of the BirA enzyme that localizes to the lumen of the Endoplasmic Reticulum through a signal that translocates proteins to the secretory pathway. Co-expression of VAMP-2-BAP and BirA results in a luminal biotinylated VAMP-2, which we termed 'biosyn'. Fluorescently tagged streptavidin can subsequently be used to irreversibly bind biosyn and label newly exocytosed vesicles fluorescently at presynaptic terminals.</gtr:description><gtr:id>BB584CB3-B2F8-47B9-996B-FBB5BE47E0EB</gtr:id><gtr:impact>We exploit the high affinity interaction between streptavidin and biotin to label biosyn with fluorescent streptavidin during vesicle fusion. This approach allows tagging of vesicles sequentially, to visualize and establish the identity of presynaptic pools. Using this technique we were able to distinguish between two different pools of vesicles in presynaptic terminals of hippocampal neurons: one that is released in response to presynaptic activity and another, distinct vesicle pool that spontaneously fuses with the plasma membrane.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Biotin-avidin technique for labelling presynaptic vesicles</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C0635949-B2AE-4B3E-A772-28CC62026A34"><gtr:id>C0635949-B2AE-4B3E-A772-28CC62026A34</gtr:id><gtr:title>A resting pool of vesicles is responsible for spontaneous vesicle fusion at the synapse.</gtr:title><gtr:parentPublicationTitle>Nature neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a0e6ccd36088257d2c41e738a984adb3"><gtr:id>a0e6ccd36088257d2c41e738a984adb3</gtr:id><gtr:otherNames>Fredj NB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1097-6256</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/92B1DB03-08D1-44A8-AA1D-7EFBA0209CEA"><gtr:id>92B1DB03-08D1-44A8-AA1D-7EFBA0209CEA</gtr:id><gtr:title>Studying vesicle cycling in presynaptic terminals using the genetically encoded probe synaptopHluorin.</gtr:title><gtr:parentPublicationTitle>Nature protocols</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e9f83d20bee9dc42c1ab4531035bbe5f"><gtr:id>e9f83d20bee9dc42c1ab4531035bbe5f</gtr:id><gtr:otherNames>Burrone J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1750-2799</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D894D04A-C4A0-45F3-A618-131C2B9DA0DA"><gtr:id>D894D04A-C4A0-45F3-A618-131C2B9DA0DA</gtr:id><gtr:title>Synaptic activity and activity-dependent competition regulates axon arbor maturation, growth arrest, and territory in the retinotectal projection.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/881c6e31edb1de8736207d7ebf4dec63"><gtr:id>881c6e31edb1de8736207d7ebf4dec63</gtr:id><gtr:otherNames>Ben Fredj N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0600197</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>